Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1607
    -0.0076 (-0.65%)
     
  • GBP/USD

    1.2370
    -0.0068 (-0.55%)
     
  • Bitcoin GBP

    51,388.77
    -80.49 (-0.16%)
     
  • CMC Crypto 200

    1,378.23
    +65.61 (+5.00%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     
  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

Company News for Dec 21, 2020

  • Shares of Winnebago Industries, Inc. WGO jumped 5.3% after the company reported first-quarter fiscal 2021 earnings of $1.69 per share, beating the Zacks Consensus Estimate of $1.03.

  • Apogee Enterprises, Inc.’s APOG shares rose 1.3% after the company reported third-quarter 2020 earnings of 90 cents per share, beating the Zacks Consensus Estimate of 67 cents.

  • Shares of Mereo BioPharma Group plc MREO surged 62.9% after the company announced a license and collaboration agreement for setrusumab, a monoclonal antibody in clinical development for osteogenesis imperfecta with Ultragenyx.

  • Earthstone Energy, Inc.’s ESTE shares jumped 17.7% after the company acquired Independence Resources Management for roughly $185.9 million.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Apogee Enterprises, Inc. (APOG) : Free Stock Analysis Report
 
Winnebago Industries, Inc. (WGO) : Free Stock Analysis Report
 
Earthstone Energy, Inc. (ESTE) : Free Stock Analysis Report
 
MEREO BIOPHARMA (MREO) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research